Cas:26830-40-0 2-amino-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carbonitrile manufacturer & supplier

We serve Chemical Name:2-amino-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carbonitrile CAS:26830-40-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-amino-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carbonitrile

Chemical Name:2-amino-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carbonitrile
CAS.NO:26830-40-0
Synonyms:MFCD00742042;2-Amino-3-cyano-4,5,6,7-tetrahydro-6-isopropylthieno<3,4-b>pyridine
Molecular Formula:C11H15N3S
Molecular Weight:221.32200
HS Code:2934999090

Physical and Chemical Properties:
Melting point:178-180ºC
Boiling point:401.5ºC at 760mmHg
Density:1.23g/cm3
Index of Refraction:1.614
PSA:81.29000
Exact Mass:221.09900
LogP:2.48758

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00742042 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-3-cyano-4,5,6,7-tetrahydro-6-isopropylthieno&lt Use and application,2-Amino-3-cyano-4,5,6,7-tetrahydro-6-isopropylthieno&lt technical grade,usp/ep/jp grade.


Related News: This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. Poly(O-Acetyl-1-hydroxy proline) manufacturers This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. 2,2′-(9-oxo-9H-fluorene-2,7-dicarbonyl)dibenzoic acid suppliers Sales for Tafinlar and Mekinist, the MEK inhibitor it was approved with, hit $672 million in 2016. Fast forward to 2020 and the duo generated $1.5 billion in revenue. 2-(4-Hexylphenyl)-6-octyloxybenzo[b]thiophene vendor & factory A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. ,One of the main benefits of biocatalysis is that it increases conversion efficiency for significantly higher yields with fewer by-products, equating to faster and more cost-effective production.